Document is current
Any future updates will be listed below
-
Authors
Kutzinski, Max https://orcid.org/0009-0008-8751-603X
Krause, Nicole https://orcid.org/0000-0001-6681-7054
Riemann-Lorenz, Karin https://orcid.org/0000-0002-0779-2640
Meyer, Björn https://orcid.org/0000-0003-1100-0260
Heesen, Christoph https://orcid.org/0000-0001-8131-9467
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 13 April 2023
Accepted: 11 October 2023
First Online: 23 October 2023
Declarations
:
: The study has been approved by the Ethics Committee of the Hamburg Chamber of Physicians (PV6015) and informed consent was obtained from all study participants. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: CH has received research grants, speaker honoraria and travel grants from Biogen, Celgene, Genzyme, Merck and Roche, all outside of this work. BM is employed by GAIA, the company that developed, owns and operates levidex. NK, KRL and MK have nothing to declare.
